Rep. Andy Barr Files Bill to Regulate Hemp THC Products Nationwide
Kentucky Republican introduces Lawful Hemp Protection Act as FDA prepares November enforcement deadline for intoxicating hemp cannabinoids.

A stunning daytime view of the United States Capitol in Washington DC with a clear blue sky.
Barr's Bill Sets Federal Standards for Hemp Cultivation Through Retail
The Lawful Hemp Protection Act establishes uniform federal standards for hemp cultivation, manufacturing, testing, and labeling across all 50 states. Rep. Barr filed the legislation in the House on July 21, according to congressional records. No Senate companion yet.
The framework would create consistent rules for the hemp-THC supply chain from farm to consumer: cultivation protocols, extraction and conversion standards, third-party testing requirements, and retail labeling mandates. The bill doesn't specify THC concentration limits or age restrictions in its initial language.
Barr represents Kentucky's 6th district, a major hemp-producing region. Kentucky farmers planted more than 10,000 acres of hemp in 2025, making the state the fourth-largest hemp producer nationally.
Timing Collides With FDA's November Enforcement Deadline
FDA's final rule on intoxicating hemp cannabinoids takes effect November 15, 2026, giving Congress less than four months to pass preemptive legislation. The agency published its Notice of Proposed Rulemaking in March 2026, proposing to classify delta-8 THC, delta-10 THC, THCA, and similar isomers as controlled substances when derived from hemp.
The collision creates a narrow legislative window. If Barr's bill advances through committee and reaches a floor vote before November, it could supersede FDA's enforcement authority. If it stalls, the regulatory framework goes live by default.
Hemp industry groups have lobbied for statutory clarity since the 2018 Farm Bill legalized hemp with less than 0.3% delta-9 THC by dry weight. That definition created the loophole: THCA flower and delta-8 concentrates remain legal under the letter of the law because they convert to delta-9 only after decarboxylation.
What the Bill Covers — and What It Leaves Open
The Lawful Hemp Protection Act addresses manufacturing and labeling but doesn't yet specify THC potency caps or retail age gates. Early bill language focuses on process standards rather than product restrictions. Critical variables remain unresolved.
Third-party lab testing would become mandatory for all hemp-derived consumables, including cannabinoid potency, pesticide residues, heavy metals, and microbial contaminants. Labels must disclose total THC content, serving size, and a QR code linking to full lab results. These provisions mirror state-level frameworks in California and Colorado.
What's missing: a federal THC ceiling. California caps hemp-derived delta-9 at 0.3% per serving. Ohio bans THCA flower entirely. The Lawful Hemp Protection Act doesn't pick a number, punting that decision to future rulemaking or amendment.
Kentucky's Hemp Stake in Federal Policy
Kentucky produced 10,400 acres of hemp in 2025, generating $47 million in farm-gate revenue, according to USDA data. Most of that acreage goes to CBD extraction, but THCA flower and delta-8 distillate now account for 22% of Kentucky hemp sales by dollar volume.
Barr's district includes Lexington and surrounding Bluegrass counties, where hemp replaced tobacco as the primary cash crop after 2018. The economic pressure is direct: if FDA's rule reclassifies intoxicating cannabinoids as controlled substances, Kentucky farmers lose access to their fastest-growing market segment.
Bipartisan appeal exists in agricultural states. Hemp is legal in 47 states, and 34 states have licensed hemp-THC retail programs. A federal framework that protects existing markets while imposing safety standards could attract votes from both parties.
Industry Reaction: Relief Mixed With Uncertainty
Hemp trade groups called the bill a necessary step but expressed concern over unresolved potency and age-restriction questions. The U.S. Hemp Roundtable, a Washington lobbying coalition, issued a statement supporting Barr's effort while noting the bill must address consumer safety to win Senate approval.
The missing potency cap is the sticking point. If the bill passes without a THC limit, it effectively legalizes high-potency THCA flower and delta-8 vapes with no upper bound. That outcome would alarm public health advocates and likely trigger Senate amendments.
Conversely, if Barr adds a restrictive cap in committee, he risks losing support from hemp processors who rely on high-margin intoxicating products. The legislative sweet spot — a cap high enough to preserve the market but low enough to satisfy safety concerns — has eluded Congress for six years.
What Happens If the Bill Stalls
If Congress doesn't pass the Lawful Hemp Protection Act by November 15, FDA's enforcement rule takes effect and reclassifies intoxicating hemp cannabinoids as Schedule I controlled substances. That triggers immediate consequences for retailers, processors, and farmers.
Retailers holding delta-8 or THCA inventory would face federal seizure risk. Processors with extraction licenses would need to halt production or pivot to non-intoxicating cannabinoids like CBD and CBG. Farmers growing high-THCA cultivars would lose their primary buyer base overnight.
Enforcement would vary. States with adult-use cannabis programs would likely deprioritize hemp-THC enforcement, treating it as a gray-market nuisance rather than a criminal priority. States without legal cannabis — including Kentucky — would face pressure to align with federal policy and shut down hemp-THC retail.
Next Steps: Committee Assignment and Markup
The bill now awaits assignment to the House Energy and Commerce Committee, which holds jurisdiction over FDA and food-safety law. Committee chair Frank Pallone (D-NJ) hasn't indicated whether he'll schedule a hearing. If the bill reaches markup, expect amendments on potency caps, age restrictions, and state preemption.
The clock is tight. Congress has 16 weeks of session days before the November deadline. That leaves room for one markup cycle and one floor vote if leadership prioritizes the bill. If it lands in committee and sits, the regulatory path wins by default.
For full background on federal hemp-THC enforcement and the November deadline, see the CannIntel topic hub on Federal Hemp THC Regulation. We'll be tracking committee assignments, markup language, and Senate companion filings as they emerge.
For complete background, history, and our ongoing coverage of this story:
Open the CannIntel topic hub →Frequently asked questions
What does the Lawful Hemp Protection Act regulate?
The bill establishes federal standards for hemp cultivation, manufacturing, third-party testing, and labeling. It requires cannabinoid potency disclosure, contaminant testing, and QR-linked lab results on all hemp-derived consumables. It doesn't yet specify THC concentration limits or retail age restrictions.
When does FDA's hemp-THC enforcement rule take effect?
FDA's final rule classifying delta-8 THC, delta-10 THC, THCA, and similar isomers as controlled substances takes effect November 15, 2026. If Congress passes the Lawful Hemp Protection Act before that date, the statutory framework would supersede FDA's regulatory authority.
Why doesn't the bill include a THC potency cap?
The initial bill language focuses on process standards rather than product restrictions, leaving potency limits to future rulemaking or amendment. This omission reflects the legislative challenge: a cap too low alienates hemp processors, while no cap at all raises public health concerns and risks Senate opposition.
What happens to hemp retailers if the bill fails?
If the bill doesn't pass by November 15, FDA's rule reclassifies intoxicating hemp cannabinoids as Schedule I controlled substances. Retailers holding delta-8 or THCA inventory would face federal seizure risk, and processors would need to halt production or pivot to non-intoxicating cannabinoids like CBD.
Does the bill have bipartisan support?
The bill has potential bipartisan appeal in agricultural states, as hemp is legal in 47 states and 34 states have licensed hemp-THC retail programs. However, it doesn't yet have a Senate companion measure, and its prospects depend on whether leadership prioritizes it before the November deadline.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Laws

Hemp THC Ban Poll Shows Consumers Shift to Licensed Marijuana Retailers
New survey data indicates state bans on intoxicating hemp products drive consumers toward regulated cannabis dispensaries rather than eliminating demand.

Idaho Medical Marijuana Campaign Disputes State's Ballot Rejection
Organizers challenge Secretary of State's claims about signature validity after initiative fails to qualify for November ballot.

Wisconsin Governor Urges Congress to Close Federal Hemp Loophole
Gov. Tony Evers calls on federal lawmakers to eliminate intoxicating hemp products sold outside state cannabis frameworks.
More from the newsroom

Cheech and Chong Open Cannabis Shop in Milo, Maine This Weekend
The comedy duo's first Maine dispensary launches Saturday in a rural town of 2,200 residents.

Deepak Anand Outlines International Cannabis Export Path Post-Reform
Cannabis attorney Deepak Anand details the regulatory framework for cross-border cannabis trade following federal rescheduling.

SNDL Stock Draws Investor Attention Amid Medical Cannabis Consolidation
Investors are reassessing SNDL's position as medical cannabis consolidation accelerates and U.S. market entry strategies shift.